Mumbai, May 21 : The British subsidiary of Indian drug major Cipla Ltd has acquired 51 percent equity stake in Uganda-based Quality Chemicals Ltd for USD30 million (Rs.191 crore) in tranches from its current shareholders.
Hyderabad, May 20 : The U.S. Pharmacopeial Convention (USP), a global leader in medicines quality, is bringing together national medicines control laboratory officials for a workshop on May 26-28 in Hyderabad at USP-India on improving aspects of medicines quality in the Asia-Pacific region.
New Delhi, May 13 : Drug major Lupin posted consolidated net profit of Rs.547 crore for the quarter ended March 31, 2015 compared to Rs.553 crore posted during the corresponding quarter a year back.
London, May 13 : Many fixed-dose drug combinations (FDCs) in India lack central regulatory approval despite concerns over the safety and efficacy of such combinations, say British researchers.
New Delhi /Kolkata, Apr 21 : Cirrius PharmaCRM Digital Platform on Microsoft Azure has been adopted by leading pharmaceutical companies such as Cipla, Ranbaxy and Biocon for enabling multi-channel digitization of medical engagements.
Mumbai, April 20 : The Canadian subsidiary of Mumbai-based pharmaceuticals firm Lupin Limited on Monday said it has launched its first brand product Zaxine in that country under a strategic licensing agreement.
Mumbai, March 26 : India's largest pharma company Sun Pharmaceutical Industries on Wednesday announced the closure of its merger with Ranbaxy Laboratories saying the integration will deliver synergies worth $250 million (over Rs.1,500 crore) in three years.
Kolkata, March 16 : Indian pharmaceuticals companies need to diversify their product range and focus on evolving as innovators as growth in generic market is expected to slow down over the next decade, a study by industry body Assocham said on Monday.
Mumbai, March 16 : Mumbai-based drug maker Lupin on Monday said it is in the process of acquiring the balance 40 percent stake in South African generics major Pharma Dynamics (PD).
Mumbai/Kolkata, March 11 : Market regulator Securities and Exchange Board of India (SEBI) on Wednesday prohibited Kolkata-based Asoka Lifescience Ltd. (ALL) from mobilising funds through issuance of securities as well as accessing capital markets on grounds of alleged illicit fund-raising activities.
Hyderabad, Feb 28 : Pharma major Dr. Reddy's Laboratories has said that the union budget for 2015-16 has set the stage for growth in the medium to long term.
Kolkata, Feb 20 : NATCONPH 2015-National Conference on 'Empowering Pharmaceutical and Healthcare Professionals-Vision 2020' was inaugurated on Friday by Subhashish Maity, Director, NSHM Knowledge Campus (Kolkata) Group of Institutions at the Ahindra Mancha in Kolkata.
New York, Feb 20 : Scientists have designed a new type of self-healing hydrogel that could be injected through a syringe. It can be used in killing tumours, among other applications.
Bengaluru, Feb 10 : Wipro Consumer Care and Lighting Tuesday said it has secured a court order restraining Hainz India from making or selling Glucon D energy tablets.
New Delhi, Feb 3 : GlaxoSmithKline Consumer Healthcare Limited today declared its financial results for the third quarter ended December 31, 2014 where it recorded a net sales at Rs. 975 crores, a growth of 16% over 2013.
Mumbai, Feb 3 : Pharmaceuticals-maker Lupin Tuesday said its consolidated net profit for the quarter ended Dec 31 increased by 26.32 percent to Rs.601.45 crore compared to Rs.476.13 crore for the like period in the previous fiscal.
Hyderabad, Jan 29 : Pharmaceuticals major Dr. Reddy's consolidated net profits declined by 7.09 percent due to muted growth in the US, increased in expenses and impairment charges.
New Delhi, Jan 28 : The Cabinet Committee on Economic Affairs (CCEA) Wednesday approved the proposal of drug major Lupin Ltd. to increase investment by foreign institutional investors (FIIs) to 49 percent from 33 percent.
Pittsburgh/Hyderabad, Jan 27 : Mylan Inc. on Tuesday announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences, Inc. to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir/GS-5816, once approved, in 91developing countries.
New Delhi, Jan 14 : The Delhi High court Wednesday issued notice to Switzerland-based Novartis AG on a plea by pharmaceutical firm Cipla, challenging a single judge bench's order that temporarily restrained it from manufacturing or selling any drug containing chemical Indacaterol, used for treating chronic respiratory disease.
New Delhi, Jan 13 : Pharmaceutical firm Cipla Tuesday moved the Delhi High Court, challenged its single judge bench's order temporarily restraining from manufacturing or selling any drug containing chemical indacaterol, used for treating chronic respiratory disease.
Mumbai, Jan 13 : The pharmaceutical solutions division of $750 million conglomerate Piramal Enterprises Limited (PEL) Tuesday said it is planning to invest $40 million on new equipment and modern technologies.
New Delhi, Jan 5 : To bring some relief to the people in the winters, Mumbai-based Pantheon PharmChem launched WARMEE, an innovative handy self-heating pouch, a company statement said here Monday.